Skip to main content

Oncology

Leukemia, Oncology

Zanubrutinib, Next-Generation BTK, Leads to Impressive Responses in Patients with CLL or SLL

Phoebe Starr

Breast Cancer, FDA Approvals, Oncology

Enhertu, a Dual-Targeted Therapy, Approved for Metastatic HER2-Positive Breast Cancer

Leukemia, Oncology, Practice Management

First National Study: Geographic Socioeconomic Disparities Mirror Substantial Gaps in Survival in Children with AML

Chase Doyle

FDA Approvals, Pancreatic Cancer, Oncology

Lynparza Indicated for Maintenance Treatment of Metastatic Pancreatic Cancer with BRCA Mutation

In the Literature, Oncology

Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes

In the Literature, Oncology

Split-Fill Program for Oncology Oral Medications Is Cost-Saving

Multiple Myeloma, Oncology

Dual-Targeted CAR T-Cell Therapy Leads to Very High Response Rates in Relapsed or Refractory Multiple Myeloma

Phoebe Starr

Cholangiocarcinoma, Oncology

Surgery for Cholangiocarcinoma

In the Literature, Oncology

Real-World Evidence Supports Patient Navigation in Cancer

In the Literature, Oncology

Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes

Page 7 of 27
Results 61 - 70 of 262